跳至主要内容
临床试验/CTRI/2021/01/030497
CTRI/2021/01/030497尚未招募未知

Clinical study to evaluate the effect of Madhutailika Basti on humoral immunity with respect to immunoglobulin G in Type II Diabetes Mellitus

SDM College of Ayurveda and Hospital Hassan Karnataka0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient fulfilling the diagnostic criteria of Prameha.
  • Patients fit for Basti Karma.
  • Patients with clinical positive history of Type II Diabetes for 5 to 10 years.
  • Patients who give informed consent.

排除标准

  • Patients with PPBS >320mg/dl, HbA1C above 10.
  • History of frequent and/ severe allregic reactions with multiple medications.
  • Diagnosed cases of other Endocrine and Metabolic disorders.
  • Patients with Type I DM, Infectious diseases, Malignancy.
  • Chain smokers, alcoholics, pregnant and lactating women.
  • Patients unsuitable for Basti karma.
  • Patients with other diabetic complications like Nephropathy, Diabetic Heart Disease, Ketoacidosis.

研究者

发起方
SDM College of Ayurveda and Hospital Hassan Karnataka

相似试验